Ebola Clinical Trial to Begin Amid Outbreak in DRC
Ebola Clinical Trial to Begin Amid Outbreak in DRC
The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.
Ebola Clinical Trial to Begin Amid Outbreak in DRC
Ebola Clinical Trial to Begin Amid Outbreak in DRC

The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.

The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.

monoclonal antibodies
Antibody Combo Knocks Down HIV in Clinical Trials
Antibody Combo Knocks Down HIV in Clinical Trials
Kerry Grens | Sep 26, 2018
Some patients could suppress the virus without antiretroviral therapy for months after the drug infusions.
Ebola Update: More Experimental Treatments, Health Workers at Risk
Ebola Update: More Experimental Treatments, Health Workers at Risk
Catherine Offord | Aug 23, 2018
The number of cases in Democratic Republic of Congo’s latest outbreak of the virus has now surpassed 100.  
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Shawna Williams | Aug 14, 2018
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.
Using Mimics to Get Around Antibodies’  Limitations
Using Mimics to Get Around Antibodies’ Limitations
Devika G. Bansal | Jun 1, 2018
Synthetic and natural alternatives to traditional antibodies offer more control, specificity, and reproducibility. 
DNA-Delivered Antibodies Fight Off Lethal Bacterial Infection
DNA-Delivered Antibodies Fight Off Lethal Bacterial Infection
Catherine Offord | Oct 3, 2017
Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.
Technique Rapidly Generates Monoclonal Antibodies In Vitro
Technique Rapidly Generates Monoclonal Antibodies In Vitro
Josh P. Roberts | Jul 25, 2017
A new method stimulates B cells to make human antigen-specific antibodies, obviating the need for vaccinating blood donors or hunting for rare B cells.
Image of the Day: Fighting Filoviruses
Image of the Day: Fighting Filoviruses
The Scientist Staff | Apr 5, 2017
Researches develop a human monoclonal antibody against two filoviruses, Marburg and Ravn, which, like Ebola, can cause hemorrhagic fever.
Infographic: Inside Melanoma Invasion
Infographic: Inside Melanoma Invasion
Catherine Offord | Mar 31, 2017
See what cytokine activity and cellular starvation have to do with cancer metastasis.
Infographic: Antibody Cancer Therapy
Infographic: Antibody Cancer Therapy
Ruth Williams | Mar 31, 2017
An experimental technique removes T cells that aid in vitro tumor growth.